Lyphe vs Mamedica: Which UK Cannabis Clinic to Choose?

Lyphe vs Mamedica: best UK cannabis clinics Comparison

The private best UK cannabis clinics market in the UK has expanded significantly, with Lyphe (formerly known as Sapphire) and Mamedica emerging as two prominent providers. Both organisations offer medical cannabis access to eligible patients, but they differ in their approach, pricing, and overall service delivery. This comprehensive comparison explores the key differences to help patients make an informed decision.

Cost and Pricing Structure

Lyphe operates a tiered consultation model, with initial assessments starting around £99, whilst repeat consultations typically cost £50-£75. Prescription fees for cannabis products range from £150-£300 per month depending on dosage and formulation. The clinic offers a more accessible entry point for patients seeking initial evaluations.

Mamedica generally charges higher consultation fees, with initial assessments ranging from £150-£200. Follow-up consultations cost approximately £75-£100. Monthly prescription costs are similarly positioned to Lyphe, though Mamedica often requires additional appointments for dose titration, potentially increasing overall treatment costs. Neither clinic is typically available on NHS prescription, meaning patients bear full private costs.

Conditions Treated

Both clinics treat a range of conditions, though their specialisms vary. Lyphe has extensive experience with chronic pain, multiple sclerosis, epilepsy, anxiety, and post-traumatic stress disorder. The clinic maintains detailed outcome data and publishes research supporting its treatment protocols.

Mamedica similarly covers chronic pain, neurological conditions, and anxiety disorders. The clinic also emphasises treatment for chemotherapy-related nausea and palliative care applications. Mamedica’s practitioners often have backgrounds in pain medicine and anaesthetics, which may benefit patients with complex pain syndromes.

Wait Times

Lyphe currently operates with relatively short wait times, typically offering initial appointments within 2-4 weeks. The clinic’s expansion and streamlined digital processes have enabled faster access. Subsequent appointments can often be scheduled within days.

Mamedica’s wait times are generally longer, with initial appointments sometimes extending 6-8 weeks, particularly for their more experienced consultants. During peak periods, waiting lists can extend further. This delay may reflect the clinic’s smaller operational scale compared to Lyphe’s growing infrastructure.

Patient Experience

Lyphe emphasises accessibility through its digital-first approach. Consultations via video call are standard, reducing travel requirements for patients across the UK. The clinic provides detailed patient education materials and maintains an active online community. Patient feedback often highlights the thoroughness of initial assessments and clear communication from clinicians.

Mamedica offers a more traditional, personalised approach. Whilst telehealth is available, the clinic emphasises face-to-face consultations where possible. Patients report feeling well-heard and benefit from the consultants’ specialist medical backgrounds. However, the smaller operation means less standardisation in patient experience across different practitioners.

Product Range

Lyphe prescribes a comprehensive range of cannabis-based medicinal products, including Nabilone, Sativex, and full-spectrum flower products from UK-cultivated suppliers. The clinic works with multiple suppliers, enabling choice between different cannabinoid profiles and product formats. Patients can access oils, capsules, and dried flower preparations.

Mamedica offers a similarly broad product range, including Nabilone and Sativex, alongside access to imported and domestically produced full-spectrum products. The clinic’s specialist practitioners often develop bespoke treatment protocols combining different products for individual patient needs. Supply consistency can occasionally be challenging, particularly for specific product combinations.

Comparison Table

Criterion	Lyphe	Mamedica
Initial Consultation Fee	£99	£150-£200
Follow-up Consultation Fee	£50-£75	£75-£100
Monthly Prescription Cost	£150-£300	£150-£350
Initial Appointment Wait Time	2-4 weeks	6-8 weeks
Consultation Format	Digital-first	Mixed (preferring face-to-face)
Product Range	Extensive multi-supplier range	Comprehensive with specialist selection
Primary Strength	Accessibility and speed	Specialist expertise and customisation

“`

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Medical cannabis is a prescription-only medicine in the UK. Always consult a qualified healthcare professional. CannaZen is an information platform, not a medical provider.